Kato, Y., Azuma, K., Yamaguchi, K., Yokoyama, T., Kuyama, S., Sakamoto, K., Uno, H., Yoshida, M., Ohashi, K. (2026). A multi-institutional, single-arm, phase 2 study of durvalumab plus amrubicin in patients with relapsed extensive-stage small cell lung cancer (Aphrodite trial).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8105